LAMB2 and fibrosarcoma: In addition, the pathological potential of the LRP/LR-laminin interaction has been targeted using other anti-LRP/LR tools such as heparan mimetic HM2602, pentosan polysulfates and antibodies, single-chain variable fragment (scFv) and IgG1-iS18, resulting in a significant obstruction of the adhesive and invasive potential of HT1080 human fibrosarcoma cells [30].